Industry Research Reports

Home > Reports > Pharma & Healthcare > Metabotropic Glutamate Receptor (MRG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Metabotropic Glutamate Receptor (MRG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 101 Pages

Report ld: 2333632

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.

The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Metabotropic Glutamate Receptor (MRG) include Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics and Taisho Pharmaceutical Holding, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor (MRG), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metabotropic Glutamate Receptor (MRG) by region & country, by Type, and by Application.

The Metabotropic Glutamate Receptor (MRG) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor (MRG).

Market Segmentation

Report Metric
Details
Report Title
Metabotropic Glutamate Receptor (MRG) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Metabotropic Glutamate Receptor (MRG) Companies Covered
Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics, Taisho Pharmaceutical Holding
Global Metabotropic Glutamate Receptor (MRG) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metabotropic Glutamate Receptor (MRG) Market, Segment by Type
mGluR2

mGluR4

mGluR5
Global Metabotropic Glutamate Receptor (MRG) Market, Segment by Application
Meningitis

Septicemia

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Metabotropic Glutamate Receptor (MRG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Metabotropic Glutamate Receptor (MRG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Metabotropic Glutamate Receptor (MRG) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Metabotropic Glutamate Receptor (MRG) Product Introduction
    1.2 Global Metabotropic Glutamate Receptor (MRG) Market Size Forecast
        1.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030)
        1.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume (2019-2030)
        1.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Price (2019-2030)
    1.3 Metabotropic Glutamate Receptor (MRG) Market Trends & Drivers
        1.3.1 Metabotropic Glutamate Receptor (MRG) Industry Trends
        1.3.2 Metabotropic Glutamate Receptor (MRG) Market Drivers & Opportunity
        1.3.3 Metabotropic Glutamate Receptor (MRG) Market Challenges
        1.3.4 Metabotropic Glutamate Receptor (MRG) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Metabotropic Glutamate Receptor (MRG) Players Revenue Ranking (2023)
    2.2 Global Metabotropic Glutamate Receptor (MRG) Revenue by Company (2019-2024)
    2.3 Global Metabotropic Glutamate Receptor (MRG) Players Sales Volume Ranking (2023)
    2.4 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Company Players (2019-2024)
    2.5 Global Metabotropic Glutamate Receptor (MRG) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Metabotropic Glutamate Receptor (MRG)
    2.9 Metabotropic Glutamate Receptor (MRG) Market Competitive Analysis
        2.9.1 Metabotropic Glutamate Receptor (MRG) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Metabotropic Glutamate Receptor (MRG) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor (MRG) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 mGluR2
        3.1.2 mGluR4
        3.1.3 mGluR5
    3.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type
        3.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Type (2019-2030)
        3.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Type (%) (2019-2030)
    3.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type
        3.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Type (2019-2030)
        3.3.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Metabotropic Glutamate Receptor (MRG) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Meningitis
        4.1.2 Septicemia
        4.1.3 Others
    4.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application
        4.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Application (2019-2030)
        4.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Value, by Application (%) (2019-2030)
    4.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application
        4.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Application (2019-2030)
        4.3.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Metabotropic Glutamate Receptor (MRG) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region
        5.1.1 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2019-2024)
        5.1.3 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2025-2030)
        5.1.4 Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (%), (2019-2030)
    5.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region
        5.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2019-2024)
        5.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2025-2030)
        5.2.4 Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (%), (2019-2030)
    5.3 Global Metabotropic Glutamate Receptor (MRG) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        5.4.2 North America Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        5.5.2 Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        5.6.2 Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        5.7.2 South America Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value
        6.2.1 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.3.2 United States Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.4.2 Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.5.2 China Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.6.2 Japan Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.7.2 South Korea Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.8.2 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Metabotropic Glutamate Receptor (MRG) Sales Value, 2019-2030
        6.9.2 India Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Metabotropic Glutamate Receptor (MRG) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Addex Therapeutics
        7.1.1 Addex Therapeutics Company Information
        7.1.2 Addex Therapeutics Introduction and Business Overview
        7.1.3 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
        7.1.5 Addex Therapeutics Recent Development
    7.2 Domain Therapeutics
        7.2.1 Domain Therapeutics Company Information
        7.2.2 Domain Therapeutics Introduction and Business Overview
        7.2.3 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
        7.2.5 Domain Therapeutics Recent Development
    7.3 Medgenics
        7.3.1 Medgenics Company Information
        7.3.2 Medgenics Introduction and Business Overview
        7.3.3 Medgenics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Medgenics Metabotropic Glutamate Receptor (MRG) Product Offerings
        7.3.5 Medgenics Recent Development
    7.4 Prexton Therapeutics
        7.4.1 Prexton Therapeutics Company Information
        7.4.2 Prexton Therapeutics Introduction and Business Overview
        7.4.3 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
        7.4.5 Prexton Therapeutics Recent Development
    7.5 Taisho Pharmaceutical Holding
        7.5.1 Taisho Pharmaceutical Holding Company Information
        7.5.2 Taisho Pharmaceutical Holding Introduction and Business Overview
        7.5.3 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Offerings
        7.5.5 Taisho Pharmaceutical Holding Recent Development

 8 Industry Chain Analysis
    8.1 Metabotropic Glutamate Receptor (MRG) Industrial Chain
    8.2 Metabotropic Glutamate Receptor (MRG) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Metabotropic Glutamate Receptor (MRG) Sales Model
        8.5.2 Sales Channel
        8.5.3 Metabotropic Glutamate Receptor (MRG) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Metabotropic Glutamate Receptor (MRG) Market Trends
    Table 2. Metabotropic Glutamate Receptor (MRG) Market Drivers & Opportunity
    Table 3. Metabotropic Glutamate Receptor (MRG) Market Challenges
    Table 4. Metabotropic Glutamate Receptor (MRG) Market Restraints
    Table 5. Global Metabotropic Glutamate Receptor (MRG) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Company (2019-2024)
    Table 7. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Metabotropic Glutamate Receptor (MRG) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Metabotropic Glutamate Receptor (MRG) Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Metabotropic Glutamate Receptor (MRG) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Metabotropic Glutamate Receptor (MRG) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Metabotropic Glutamate Receptor (MRG)
    Table 13. Global Metabotropic Glutamate Receptor (MRG) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor (MRG) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Metabotropic Glutamate Receptor (MRG) Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Metabotropic Glutamate Receptor (MRG) Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Metabotropic Glutamate Receptor (MRG) Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Metabotropic Glutamate Receptor (MRG) Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Metabotropic Glutamate Receptor (MRG) Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Metabotropic Glutamate Receptor (MRG) Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Volume, (2025-2030) & (K Units)
    Table 57. Addex Therapeutics Company Information
    Table 58. Addex Therapeutics Introduction and Business Overview
    Table 59. Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
    Table 61. Addex Therapeutics Recent Development
    Table 62. Domain Therapeutics Company Information
    Table 63. Domain Therapeutics Introduction and Business Overview
    Table 64. Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
    Table 66. Domain Therapeutics Recent Development
    Table 67. Medgenics Company Information
    Table 68. Medgenics Introduction and Business Overview
    Table 69. Medgenics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Medgenics Metabotropic Glutamate Receptor (MRG) Product Offerings
    Table 71. Medgenics Recent Development
    Table 72. Prexton Therapeutics Company Information
    Table 73. Prexton Therapeutics Introduction and Business Overview
    Table 74. Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Offerings
    Table 76. Prexton Therapeutics Recent Development
    Table 77. Taisho Pharmaceutical Holding Company Information
    Table 78. Taisho Pharmaceutical Holding Introduction and Business Overview
    Table 79. Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Offerings
    Table 81. Taisho Pharmaceutical Holding Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Metabotropic Glutamate Receptor (MRG) Downstream Customers
    Table 85. Metabotropic Glutamate Receptor (MRG) Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metabotropic Glutamate Receptor (MRG) Product Picture
    Figure 2. Global Metabotropic Glutamate Receptor (MRG) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Metabotropic Glutamate Receptor (MRG) Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Metabotropic Glutamate Receptor (MRG) Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Metabotropic Glutamate Receptor (MRG) Report Years Considered
    Figure 7. Global Metabotropic Glutamate Receptor (MRG) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Metabotropic Glutamate Receptor (MRG) Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Metabotropic Glutamate Receptor (MRG) Revenue in 2023
    Figure 10. Metabotropic Glutamate Receptor (MRG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. mGluR2 Picture
    Figure 12. mGluR4 Picture
    Figure 13. mGluR5 Picture
    Figure 14. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Metabotropic Glutamate Receptor (MRG) Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Metabotropic Glutamate Receptor (MRG) Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Metabotropic Glutamate Receptor (MRG) Price by Type (2019-2030) & (USD/Unit)
    Figure 19. Product Picture of Meningitis
    Figure 20. Product Picture of Septicemia
    Figure 21. Product Picture of Others
    Figure 22. Global Metabotropic Glutamate Receptor (MRG) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Metabotropic Glutamate Receptor (MRG) Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Metabotropic Glutamate Receptor (MRG) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Metabotropic Glutamate Receptor (MRG) Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Metabotropic Glutamate Receptor (MRG) Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Metabotropic Glutamate Receptor (MRG) Sales Volume (%), (2019-2030)
    Figure 39. United States Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Metabotropic Glutamate Receptor (MRG) Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Metabotropic Glutamate Receptor (MRG) Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Metabotropic Glutamate Receptor (MRG) Sales Value by Application (%), 2023 VS 2030
    Figure 60. Metabotropic Glutamate Receptor (MRG) Industrial Chain
    Figure 61. Metabotropic Glutamate Receptor (MRG) Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.

The global market for Metabotropic Glutamate Receptor (MRG) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Metabotropic Glutamate Receptor (MRG) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Metabotropic Glutamate Receptor (MRG) include Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics and Taisho Pharmaceutical Holding, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Metabotropic Glutamate Receptor (MRG), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metabotropic Glutamate Receptor (MRG) by region & country, by Type, and by Application.

The Metabotropic Glutamate Receptor (MRG) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabotropic Glutamate Receptor (MRG).

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 101 Pages

Report ld: 2333632

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License